e-Drug3D

149

OXTRIPHYLLINE

DISCONTINUED


INN
OXTRIPHYLLINE

cas 46155-92-4
CLASS

RESPIRATORY SYSTEM
BRONCHODILATOR AGENTS

ROUTE (list)

ORAL

ATC code

R03DA02
R03DB02

PK parameters

F 90 PERCENT (PMID7034918)

Target

-

DrugCentral

Adenosine receptor A2a UNIPROT P29274 ADORA2A

Adenosine receptor A1 UNIPROT P30542 ADORA1

Download SDF file 1,3-dimethyl-2-oxopurin-6-olate

Formula:
C7H7N4O2

Calculated chemical properties:

MW 179.17
NB_atoms 13
XLogP -1.41
PSA 61.111
NB_HD 0
NB_HA 6
fsp3 0.29
Lipinski(0=no;1=yes) 1

FDA
NDA 009268 (pdf not found) INN (OXTRIPHYLLINE) CHOLEDYL (PARKE DAVIS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 087835 (pdf not found) INN (OXTRIPHYLLINE) OXTRIPHYLLINE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 087866 (pdf not found) INN (OXTRIPHYLLINE) OXTRIPHYLLINE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 088242 (pdf not found) INN (OXTRIPHYLLINE) OXTRIPHYLLINE PEDIATRIC (MORTON GROVE) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 088243 (pdf not found) INN (OXTRIPHYLLINE) OXTRIPHYLLINE (MORTON GROVE) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 086742 (pdf not found) INN (OXTRIPHYLLINE) CHOLEDYL SA (WARNER CHILCOTT LLC) APPROVAL= AP YEAR= 1981 DISCONTINUED
NDA 087863 (pdf not found) INN (OXTRIPHYLLINE) CHOLEDYL SA (WARNER CHILCOTT LLC) APPROVAL= AP YEAR= 1983 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL